02
Mar
Alam et al., 2007 [28]0.48 (0.29-0.68), 13/270.52 (0.32-0.71), 14/270.81 (0.62-0.94), 22/271.00 (0.87-1.00), 26/260.92 (0.75-0.99), 24/260. defined relating to 2008 Western Corporation for Study and Treatment of Malignancy/Mycoses Study Group criteria. Level of sensitivity, specificity and diagnostic Madecassic acid odds ratios (DOR) were determined for Mn, A-Mn and combined Mn/A-Mn testing. Results Overall, 14 studies that comprised 453 individuals and 767 handles had been reviewed. The individual populations contained in the research had been generally haematological and cancers situations in seven research and mainly intense care device and surgery situations in the various other seven research. All scholarly research but 1…